Neuronoff Closes Oversubscribed $4.5M Round to Prepare Launch of Injectrode Platform for Chronic Pain
CLEVELAND, Oct. 8, 2025 /PRNewswire/ — Neuronoff, Inc., a clinical-stage medical device company pioneering minimally invasive pain treatments, today announced the closure of an oversubscribed $4.5 million financing round to advance its Injectrode® platform toward FDA clearance…